筋機能的磁気共鳴画像法を用いた異なる方向への股関節外転運動後の股関節外転筋群の筋活動の経時的変化

首都大学東

筋機能的磁気共鳴画像法を用いた股関節外転運動後の股関節外転筋群の継時的な筋活動の変化

The hip abductor muscles play an important role in postural control. Structural differences in the hip abductor muscles translate to differences in functional activity. This study sought to measure changes in T2 values of the hip abductors after hip abduction exercise over time and to identify variations in activity between the different hip abductor muscle groups. Ten healthy young men (mean age 28.4 [24−32] years) performed 5 sets of 40 repetitions of a hip abduction exercise at 30% maximum voluntary contraction with the right leg. Magnetic resonance imaging was performed before exercise, at intervals during exercise, and at the end of exercise. Subsequently, T2 values were measured for the tensor fasciae latae, gluteus minimus, the anterior, middle, and posterior segments of the gluteus medius, and the upper fibers of the gluteus maximus. T2 values for the gluteus minimus, tensor fasciae latae, and the anterior and middle segments of the gluteus medius were significantly higher at after all exercise compared with before exercise. However, T2 values for the posterior segments of the gluteus medius after 3, 4, and 5 sets of exercise were significantly higher than before exercise. T2 values for the upper fibers of the gluteus maximus after 4 and 5 sets were significantly higher than before exercise. Thus, the variable changes in muscle activity observed in this study were attributable to differences in anatomic structure and reflected intramuscular variation in activity between the hip abductor muscles.首都大学東京学位論文甲第959号副論

Superwind-Driven Intense H_2 Emission in NGC 6240

We have performed a long-slit K band spectroscopic observation of the luminous infrared galaxy NGC 6240. The peak position of the H_2 v=1-0 S(1) emission in the slit is located ~0.3" - 0.4" north of the southern nucleus. It is almost the midpoint between the southern nucleus and the peak position of the ^12CO J=1-0 emission. Based on the line-ratio analyses, we suggest the excitation mechanism of H_2 is pure thermal at most positions. In the southern region we find the following three velocity components in the H_2 emission: the blueshifted shell component (~-250 km s^-1 with respect to V_sys) which is recognized as a distinct C-shape distortion in the velocity field around the southern nucleus, the high-velocity blueshifted ``wing'' component (~-1000 km s^-1 with respect to V_sys), and the component indicating possible line splitting of ~500 km s^-1. The latter two components are extended to the south from the southern nucleus. We show that the kinematic properties of these three components can be reproduced by expanding motion of a shell-like structure around the southern nucleus. The offset peak position of the H_2 emission can be understood if we assume that the shell expanding to the north interacts with the extragalactic molecular gas. At the interface between the shell and the molecular gas concentration the cloud-crushing mechanism proposed by Cowie et al. (1981) may work efficiently, and the intense H_2 emission is thus expected there. All these findings lead us to propose a model that the most H_2 emission is attributed to the shock excitation driven by the superwind activity of the southern nucleus.Comment: 33 pages, 9 figures, accepted for publication in PAS

Influence of the Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster on the birth weight of newborns in Fukushima Prefecture: Fukushima Health Management Survey

Objective: The Great East Japan Earthquake and Fukushima Daiichi nuclear disaster occurred on 11 March 2011. We investigated the incidence of SGA (small for gestational age) in the Fukushima Prefecture in newborns delivered by women who were pregnant at the time of the disasters and identified any risk factors for SGA. Methods: Subjects were women who were pregnant at the time of the disasters. Questionnaires were sent to the women who lived in the Hamadori area (seaside and near to the nuclear power plant) at the time of the disasters as well as to a control group of women who lived outside the Hamadori area. The incidence of SGA was compared. Logistic regression analysis was performed to identify the risk factors for SGA. Results: In total, 325(5.6%) women had infants with SGA. Neither area nor the trimester of pregnancy at the time of the disasters influenced the incidence of SGA. Pregnancy-induced hypertension (PIH) was higher in the SGA group. PIH was found to be an independent risk factor for SGA. Conclusion: We found no evidence that the Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster increased the incidence of SGA in the Fukushima Prefecture

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

神経芽腫の新たな診断法と治療戦略を創出 --がん細胞の生存戦略「がん代謝」を逆用する--. 京都大学プレスリリース. 2022-11-02.Neuroblastomas require novel therapies that are based on the exploitation of their biological mechanism. To address this need, we analyzed the DNA methylation and expression datasets of neuroblastomas, extracted a candidate gene characterizing the aggressive features, and conducted functional studies. Based on the DNA methylation data, we identified a subgroup of neuroblastoma cases with 11q loss of heterozygosity with extremely poor prognosis. PHGDH, a serine metabolism-related gene, was extracted as a candidate with strong expression and characteristic methylation in this subgroup as well as in cases with MYCN amplification. PHGDH inhibition suppressed neuroblastoma cell proliferation in vitro and in vivo, indicating that the inhibition of serine metabolism by PHGDH inhibitors is a therapeutic alternative for neuroblastoma. Inhibiting the arginine metabolism, which is closely related to serine metabolism using arginine deiminase, had a combination effect both in vitro and in vivo, especially on extracellular arginine-dependent neuroblastoma cells with ASS1 deficiency. Expression and metabolome analyses of post-dose cells confirmed the synergistic effects of treatments targeting serine and arginine indicated that xCT inhibitors that inhibit cystine uptake could be candidates for further combinatorial treatment. Our results highlight the rational therapeutic strategy of targeting serine/arginine metabolism for intractable neuroblastoma

Usefulness of Combined Various Neuropsychological Tests for Assessing Difficulty of Visual Perception : A Case Report

発達障害をともなうことによって生じる困難は個人によって異なってくることから、個に応じた各種神経心理学的検査の適用を検討する必要がある。本論文では軽度知的障害、てんかんおよび注意欠陥/多動性障害をともない、さらに視覚認知の困難を主とした学習面での種々の困難を抱える一事例における神経心理学的評価とそれにもとづく支援の検討を行った。その結果、従来の標準的評価手法のみでは十分に捉えきれない要素に関する各種神経心理学的評価の重要性が示された

Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol

We reviewed and categorized 638 of 809 patients who were registered in the Japan Adult Leukemia Study Group acute myeloid leukemia (AML)-97 protocol using morphological means. Patients with the M3 subtype were excluded from the study group. According to the WHO classification, 171 patients (26.8%) had AML with recurrent genetic abnormalities, 133 (20.8%) had AML with multilineage dysplasia (MLD), 331 (51.9%) had AML not otherwise categorized, and 3 (0.5%) had acute leukemia of ambiguous lineage. The platelet count was higher and the rate of myeloperoxidase (MPO)-positive blasts was lower in AML with MLD than in the other WHO categories. The outcome was significantly better in patients with high (≥50%) than with low (<50%) ratios of MPO-positive blasts (P < 0.01). The 5-year survival rates for patients with favorable, intermediate, and adverse karyotypes were 63.4, 39.1, and 0.0%, respectively, and 35.5% for those with 11q23 abnormalities (P < 0.0001). Overall survival (OS) did not significantly differ between nine patients with t(9;11) and 23 with other 11q23 abnormalities (P = 0.22). Our results confirmed that the cytogenetic profile, MLD phenotype, and MPO-positivity of blasts are associated with survival in patients with AML, and showed that each category had the characteristics of the WHO classification such as incidence, clinical features, and OS

Large-scale identification and characterization of alternative splicing variants of human gene transcripts using 56 419 completely sequenced and manually annotated full-length cDNAs

We report the first genome-wide identification and characterization of alternative splicing in human gene transcripts based on analysis of the full-length cDNAs. Applying both manual and computational analyses for 56 419 completely sequenced and precisely annotated full-length cDNAs selected for the H-Invitational human transcriptome annotation meetings, we identified 6877 alternative splicing genes with 18 297 different alternative splicing variants. A total of 37 670 exons were involved in these alternative splicing events. The encoded protein sequences were affected in 6005 of the 6877 genes. Notably, alternative splicing affected protein motifs in 3015 genes, subcellular localizations in 2982 genes and transmembrane domains in 1348 genes. We also identified interesting patterns of alternative splicing, in which two distinct genes seemed to be bridged, nested or having overlapping protein coding sequences (CDSs) of different reading frames (multiple CDS). In these cases, completely unrelated proteins are encoded by a single locus. Genome-wide annotations of alternative splicing, relying on full-length cDNAs, should lay firm groundwork for exploring in detail the diversification of protein function, which is mediated by the fast expanding universe of alternative splicing variants

Proteomic Identification of Protein Targets for 15-Deoxy-Δ12,14-Prostaglandin J2 in Neuronal Plasma Membrane

15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is one of factors contributed to the neurotoxicity of amyloid β (Aβ), a causative protein of Alzheimer's disease. Type 2 receptor for prostaglandin D2 (DP2) and peroxysome-proliferator activated receptorγ (PPARγ) are identified as the membrane receptor and the nuclear receptor for 15d-PGJ2, respectively. Previously, we reported that the cytotoxicity of 15d-PGJ2 was independent of DP2 and PPARγ, and suggested that 15d-PGJ2 induced apoptosis through the novel specific binding sites of 15d-PGJ2 different from DP2 and PPARγ. To relate the cytotoxicity of 15d-PGJ2 to amyloidoses, we performed binding assay [3H]15d-PGJ2 and specified targets for 15d-PGJ2 associated with cytotoxicity. In the various cell lines, there was a close correlation between the susceptibilities to 15d-PGJ2 and fibrillar Aβ. Specific binding sites of [3H]15d-PGJ2 were detected in rat cortical neurons and human bronchial smooth muscle cells. When the binding assay was performed in subcellular fractions of neurons, the specific binding sites of [3H]15d-PGJ2 were detected in plasma membrane, nuclear and cytosol, but not in microsome. A proteomic approach was used to identify protein targets for 15d-PGJ2 in the plasma membrane. By using biotinylated 15d-PGJ2, eleven proteins were identified as biotin-positive spots and classified into three different functional proteins: glycolytic enzymes (Enolase2, pyruvate kinase M1 (PKM1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)), molecular chaperones (heat shock protein 8 and T-complex protein 1 subunit α), cytoskeletal proteins (Actin β, F-actin-capping protein, Tubulin β and Internexin α). GAPDH, PKM1 and Tubulin β are Aβ-interacting proteins. Thus, the present study suggested that 15d-PGJ2 plays an important role in amyloidoses not only in the central nervous system but also in the peripheral tissues

Tokyo Guidelines 2018 management bundles for acute cholangitis and cholecystitis

Management bundles that define items or procedures strongly recommended in clinical practice have been used in many guidelines in recent years. Application of these bundles facilitates the adaptation of guidelines and helps improve the prognosis of target diseases. In Tokyo Guidelines 2013 (TG13), we proposed management bundles for acute cholangitis and cholecystitis. Here, in Tokyo Guidelines 2018 (TG18), we redefine the management bundles for acute cholangitis and cholecystitis. Critical parts of the bundles in TG18 include the diagnostic process, severity assessment, transfer of patients if necessary, and therapeutic approach at each time point. Observance of these items and procedures should improve the prognosis of acute cholangitis and cholecystitis. Studies are now needed to evaluate the dissemination of these TG18 bundles and their effectiveness. Free full articles and mobile app of TG18 are available at: . Related clinical questions and references are also include